BIOMAT Database Logo BIOMAT Database Logo

Metabolism of hydralazine in man. 1977

J Wagner, and J W Faigle, and P Imhof, and G Liehr

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

J Wagner, and J W Faigle, and P Imhof, and G Liehr
Metabolism and disposition of hydralazine-14C in man and dog.
January 1974, Drug metabolism and disposition: the biological fate of chemicals,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Hydralazine elimination in man.
January 1973, Clinical pharmacology and therapeutics,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Studies on hydralazine. III. Bioavailability of hydralazine in man.
January 1976, European journal of clinical pharmacology,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Metabolism of hydralazine.
January 1977, Drug metabolism reviews,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Electrophysiologic properties of hydralazine in man.
September 1980, Pacing and clinical electrophysiology : PACE,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.
April 1981, British journal of clinical pharmacology,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Metabolism of hydralazine in man. Investigation of features relevant to drug safety, Part I.
January 1981, Arzneimittel-Forschung,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
Metabolism of hydralazine in man. Part II: Investigation of features relevant to drug safety.
February 1987, Arzneimittel-Forschung,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
The in vitro metabolism of hydralazine.
January 1985, Drug metabolism and disposition: the biological fate of chemicals,
J Wagner, and J W Faigle, and P Imhof, and G Liehr
From hydralazine to CGRP to man?
January 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
Copied contents to your clipboard!